|
18.04.2019 09:30:10
|
DGAP-Adhoc: Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD.
|
DGAP-Ad-hoc: Elanix Biotechnologies AG / Key word(s): Personnel ELANIX BIOTECHNOLOGIES AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD, THE VICE CHAIRMAN AND MEMBERS OF THE BOARD. Berlin, April 18 2019 - The Supervisory Board of Elanix Biotechnologies AG ("Company", "Elanix") has nominated by juridical order Professor Zhanfeng Cui and Anja Silling to become members of the Supervisory Board with immediate effect. Today, the Supervisory Board of Elanix has nominated Anja Silling to become the Chairman of the Board and Fang Bao, an existing member of the board, to be the Vice Chairman. Lee Ann Laurent-Applegate
18-Apr-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Elanix Biotechnologies AG |
| Stadthausbrücke 1-3 | |
| 20355 Hamburg | |
| Germany | |
| Phone: | +41 22 363 66 40 |
| Fax: | +41 22 363 66 41 |
| E-mail: | info@elanix-bt.com |
| Internet: | www.elanixbiotechnologies.com |
| ISIN: | DE000A0WMJQ4 |
| WKN: | A0WMJQ |
| Listed: | Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 801589 |
| End of Announcement | DGAP News Service |
|
|
801589 18-Apr-2019 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Elanix Biotechnologies AGmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Elanix Biotechnologies AGmehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.